相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Disease-related expression of the IL6/STAT3/SOCS3 signalling pathway in ulcerative colitis and ulcerative colitis-related carcinogenesis
Yi Li et al.
GUT (2010)
The Beneficial Effect of Vanillic Acid on Ulcerative Colitis
Su-Jin Kim et al.
MOLECULES (2010)
Cyclooxygenase-2 and Hypoxia-Inducible Factor-1α protein expression is related to inflammation, and up-regulated since the early steps of colorectal carcinogenesis
Francesco Mariani et al.
CANCER LETTERS (2009)
HIF-1α regulates epithelial inflammation by cell autonomous NFκB activation and paracrine stromal remodeling
Marzia Scortegagna et al.
BLOOD (2008)
Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition
Andreas Robinson et al.
GASTROENTEROLOGY (2008)
Hypoxia and gastrointestinal disease
Cormac T. Taylor et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Aggravation by selective COX-1 and COX-2 inhibitors of dextran sulfate sodium (DSS) - Induced colon lesions in rats
Mitsuaki Okayama et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Involvement of CPI-17 downregulation in the dysmotility of the colon from dextran sodium sulphate-induced experimental colitis in a mouse model
K. Sato et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2007)
Macrophage migration inhibitory factor has a proinflammatory activity via the p38 pathway in glucocorticoid-resistant ulcerative colitis
Yoh Ishiguro et al.
CLINICAL IMMUNOLOGY (2006)
The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats
A El-Medany et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2005)
Biologic therapy for inflammatory bowel disease
S Ardizzone et al.
DRUGS (2005)
Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis
J Karhausen et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
NS398 reduces hypoxia-inducible factor (HIF)-1α and HIF-1 activity:: Multiple-level effects involving cyclooxygenase-2 dependent and independent mechanisms
H Zhong et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Selective cyclooxygenase-2 inhibitors: similarities and differences
K Brune et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2004)
Cox-2 is needed but not sufficient for apoptosis induced by Cox-2 selective inhibitors in colon cancer cells
B Agarwal et al.
APOPTOSIS (2003)
Hypoxia-inducible factors 1α and 2α are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin
A Giatromanolaki et al.
MELANOMA RESEARCH (2003)
Science review:: Redox and oxygen-sensitive transcription factors in the regulation of oxidant-mediated lung injury:: Role for hypoxia-inducible factor-1α
JJ Haddad
CRITICAL CARE (2003)
Antisense oligonucleotide blockade of tumor necrosis factor-alpha in two murine models of colitis
KJ Myers et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Cytokine and anti-cytokine therapies for inflammatory bowel disease
H Ogata et al.
CURRENT PHARMACEUTICAL DESIGN (2003)
Distinct functions of COX-1 and COX-2
I Morita
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2002)
Biologic therapy of inflammatory bowel disease
WJ Sandborn et al.
GASTROENTEROLOGY (2002)
Tumour necrosis factor in mouse models of chronic intestinal inflammation
C Mueller
IMMUNOLOGY (2002)
Ixeris dentata green sap inhibits both compound 48/80-induced aanaphylaxis-like response and IgE-Mediated anaphylactic response in murine model
JM Yi et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2002)
Clinical aspects and pathophysiology of inflammatory bowel disease
BA Hendrickson et al.
CLINICAL MICROBIOLOGY REVIEWS (2002)
Neuronal COX-2 expression in human myenteric plexus in active inflammatory bowel disease
PJ Roberts et al.
GUT (2001)
The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia
SN Agoff et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)